Insights

Conversational AI is no longer just a customer service tool—it’s becoming a strategic asset in Pharma. From empowering sales reps with virtual assistants to enhancing HCP interactions and enriching CRM systems, this technology is transforming how the industry communicates and operates.

For the fifth consecutive year, Hyntelo has been ranked in the “Leader della Crescita” list, a prestigious survey conducted by Statista in partnership with IlSole24Ore. We’re thrilled to celebrate this recognition of our continued success!

The award highlights companies with the highest turnover growth over the three-year period from 2020-2023.

Art, Design, and Artificial Intelligence—what could they have in common? A few months ago, we wouldn’t have imagined needing to answer this question, but now that the sixth edition of EDIT Napoli has concluded, we definitely have some answers.

AI solutions have become an invaluable asset for marketers across every phase of product strategy. From conducting market research and analyzing data to product development, planning communication initiatives, modular content creation, and ultimately driving sales, AI is transforming the landscape.

Artificial Intelligence is reshaping the pharmaceutical industry—but the journey is far from simple. From driving innovation in content management and HCP engagement to streamlining MLR processes, AI is full of potential. Yet, data integration, strategic alignment, and regulatory hurdles remain major obstacles.

Hyntelo strengthens its partnership with Veeva, the global leader in cloud computing applied to pharmaceutical and life sciences industry. After signing a product partnership, Hyntelo has been chosen as AI Partner. A prestigious collaboration for our company, the only one in Europe to join the Veeva AI Partner Program to accelerate the use of Generative AI in life sciences.

At Hyntelo we not only develop state-of-the-art AI solutions but also integrate AI into our everyday operations across various business units. Our marketing department, in particular, has seen a transformative impact through generative AI, enhancing both our creative and strategic processes. 

Rome, May 6th, 2024 - We are thrilled to announce that Hyntelo has signed a new partnership agreement with GELLIFY, a global innovation factory that integrates strategy, design & technology, supporting companies’ growth from vision to execution through its “purple way”. The collaboration with GELLIFY aims to enhance Hyntelo delivery capacity, particularly in the pharma sector.

AI is rapidly transforming how Pharma companies connect, communicate, and compete. From content creation to personalized engagement, artificial intelligence is driving a new era of efficiency, compliance, and customer relevance.

Last week I attended Yann LeCun’s keynote at the World AI Cannes Festivalwhich captured my attention. LeCun – professor at NYU, Chief AI Scientist at Meta, winner of a Turing Award in 2018 – shared profound insights into the current state and the future trajectory of Artificial Intelligence. His presentation was not just a glimpse into the advancements in AI from a technical point of view, but a call for a shift in how we approach these systems. 

Siamo felici di annunciare che per il secondo anno consecutivo Hyntelo ha ricevuto la certificazione di Great Place To Work!

Le voci dei nostri Hyntellers si sono espresse chiare e forti, confermando che siamo un luogo di lavoro unico, in cui la soddisfazione dei dipendenti è al centro della cultura aziendale.